Tangier disease.
Mentis
S W
SW
Anesthesia Section, National Institutes of Health, Bethesda, Maryland 20892-1512, USA.
D000328:Adult; D000768:Anesthesia, General; D018685:Anesthetics, Inhalation / Q000008:administration & dosage; D018686:Anesthetics, Intravenous / Q000008:administration & dosage; D000077335:Desflurane; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D005836:Genitalia, Female / Q000601:surgery; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D007530:Isoflurane / Q000008:administration & dosage / Q000031:analogs & derivatives; D010535:Laparoscopy; D008874:Midazolam / Q000008:administration & dosage; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage; D009609:Nitrous Oxide / Q000008:administration & dosage; D011229:Preanesthetic Medication; D015742:Propofol / Q000008:administration & dosage; D013631:Tangier Disease / Q000503:physiopathology*; D014673:Vecuronium Bromide / Q000008:administration & dosage
D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D006993:Hypnotics and Sedatives; D003473:Neuromuscular Nondepolarizing Agents; D014673:Vecuronium Bromide; D000077335:Desflurane; D007530:Isoflurane; D009609:Nitrous Oxide; D008874:Midazolam; D005283:Fentanyl; D015742:Propofol